760 related articles for article (PubMed ID: 18469708)
21. [Myxoid mesenchymal tumors of uterus: endometrial stromal and smooth muscle tumors, myxoid variant].
Chesnais AL; Watkin E; Beurton D; Devouassoux-Shisheboran M
Ann Pathol; 2011 Jun; 31(3):152-8. PubMed ID: 21736994
[TBL] [Abstract][Full Text] [Related]
22. Diagnostic utility of WT1 immunostaining in ovarian sertoli cell tumor.
Zhao C; Bratthauer GL; Barner R; Vang R
Am J Surg Pathol; 2007 Sep; 31(9):1378-86. PubMed ID: 17721194
[TBL] [Abstract][Full Text] [Related]
23. Müllerian adenosarcoma presenting as cervical polyps: a report of seven cases and review of the literature.
Kerner H; Lichtig C
Obstet Gynecol; 1993 May; 81(5 ( Pt 1)):655-9. PubMed ID: 8385764
[TBL] [Abstract][Full Text] [Related]
24. CD10 immunostaining distinguishes atypical polypoid adenomyofibroma (atypical polypoid adenomyoma) from endometrial carcinoma invading the myometrium.
Ohishi Y; Kaku T; Kobayashi H; Aishima S; Umekita Y; Wake N; Tsuneyoshi M
Hum Pathol; 2008 Oct; 39(10):1446-53. PubMed ID: 18619643
[TBL] [Abstract][Full Text] [Related]
25. The Impact on Survival of an Extensive Sex Cord-like Component in Mullerian Adenosarcomas: A Study Comprising 6 Cases.
Stolnicu S; Molnar C; Barsan I; Boros M; Nogales FF; Soslow RA
Int J Gynecol Pathol; 2016 Mar; 35(2):147-52. PubMed ID: 26535983
[TBL] [Abstract][Full Text] [Related]
26. Uterine sarcomas: a review.
D'Angelo E; Prat J
Gynecol Oncol; 2010 Jan; 116(1):131-9. PubMed ID: 19853898
[TBL] [Abstract][Full Text] [Related]
27. Identification of the most sensitive and robust immunohistochemical markers in different categories of ovarian sex cord-stromal tumors.
Zhao C; Vinh TN; McManus K; Dabbs D; Barner R; Vang R
Am J Surg Pathol; 2009 Mar; 33(3):354-66. PubMed ID: 19033865
[TBL] [Abstract][Full Text] [Related]
28. Clinicopathological spectrum of 19 adenosarcomas of female genital tract, including uncommon clinical associations and immunohistochemical profile, reviewed at a single institution.
Rekhi B; Deodhar KK; Maheshwari A; Menon S; Kerkar R; Bajpai J; Ghosh J; Gupta S; Engineer R; Shrivastava SK
Indian J Pathol Microbiol; 2012; 55(3):326-32. PubMed ID: 23032825
[TBL] [Abstract][Full Text] [Related]
29. [Uterine adenosarcoma. Apropos of a case of uterine and vaginal adenosarcoma with a corrected genital prolapse].
Kabwa L; Mattei JP; Eloit S; Ramadane A; Grange B
J Chir (Paris); 1997 Jul; 134(2):80-5. PubMed ID: 9378790
[TBL] [Abstract][Full Text] [Related]
30. Immunohistochemistry as a diagnostic aid in the interpretation of unusual mesenchymal tumors of the uterus.
Devaney K; Tavassoli FA
Mod Pathol; 1991 Mar; 4(2):225-31. PubMed ID: 1710807
[TBL] [Abstract][Full Text] [Related]
31. Immunohistochemical evaluation of the c-kit proto-oncogene in sarcomas of the uterus: a case series.
Leath CA; Straughn JM; Conner MG; Barnes MN; Alvarez RD; Partridge EE; Huh WK
J Reprod Med; 2004 Feb; 49(2):71-5. PubMed ID: 15018431
[TBL] [Abstract][Full Text] [Related]
32. An immunohistochemical analysis of endometrial stromal and smooth muscle tumors of the uterus: a study of 54 cases emphasizing the importance of using a panel because of overlap in immunoreactivity for individual antibodies.
Oliva E; Young RH; Amin MB; Clement PB
Am J Surg Pathol; 2002 Apr; 26(4):403-12. PubMed ID: 11914617
[TBL] [Abstract][Full Text] [Related]
33. Uterine adenosarcomas: diagnostic use of the proliferation marker Ki-67 as an adjunct to morphologic diagnosis.
Aggarwal N; Bhargava R; Elishaev E
Int J Gynecol Pathol; 2012 Sep; 31(5):447-52. PubMed ID: 22833085
[TBL] [Abstract][Full Text] [Related]
34. [Prognosis-related clinicopathologic characteristics of FIGO stage Ⅰ Müllerian adenosarcoma of uterus].
Wang Y; Liu AJ; Chen X; Song X
Zhonghua Bing Li Xue Za Zhi; 2018 May; 47(5):334-338. PubMed ID: 29783798
[No Abstract] [Full Text] [Related]
35. Retiform uterine tumours resembling ovarian sex cord tumours. A comparative immunohistochemical study with retiform structures of the female genital tract.
Nogales FF; Stolnicu S; Harilal KR; Mooney E; García-Galvis OF
Histopathology; 2009 Mar; 54(4):471-7. PubMed ID: 19309399
[TBL] [Abstract][Full Text] [Related]
36. Late recurrence of uterine Mullerian adenosarcoma as heterologous sarcoma: Three recurrences in 8 months increasing in number and grade of sarcomatous components.
Taçkin S; Bozaci EA; Sönmezer M; Ekinci C; Ortaç F
Gynecol Oncol; 2006 Apr; 101(1):179-82. PubMed ID: 16325895
[TBL] [Abstract][Full Text] [Related]
37. Cluster of uterine mullerian adenosarcoma in the Washington, DC metropolitan area with high incidence of sarcomatous overgrowth.
Seidman JD; Wasserman CS; Aye LM; MacKoul PJ; O'Leary TJ
Am J Surg Pathol; 1999 Jul; 23(7):809-14. PubMed ID: 10403304
[TBL] [Abstract][Full Text] [Related]
38. Müllerian adenosarcoma of the cervix with heterologous elements: report of a case and review of the literature.
Ramos P; Ruiz A; Carabias E; Piñero I; Garzon A; Alvarez I
Gynecol Oncol; 2002 Jan; 84(1):161-6. PubMed ID: 11748995
[TBL] [Abstract][Full Text] [Related]
39. Immunohistochemical analysis of carcinomatous and sarcomatous components in the uterine carcinosarcoma: a case report.
Semczuk A; Skomra D; Chyzyńska M; Szewczuk W; Olcha P; Korobowicz E
Pathol Res Pract; 2008; 204(3):203-7. PubMed ID: 18207653
[TBL] [Abstract][Full Text] [Related]
40. Uterine tumors resembling ovarian sex cord tumors: an update.
Czernobilsky B
Int J Gynecol Pathol; 2008 Apr; 27(2):229-35. PubMed ID: 18317219
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
